Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:2485:255-268.
doi: 10.1007/978-1-0716-2261-2_17.

Injectable ECM Scaffolds for Cardiac Repair

Jervaughn D Hunter  1 , Todd D Johnson  1 , Rebecca L Braden  1 , Karen L Christman  2
Affiliations

Injectable ECM Scaffolds for Cardiac Repair

Jervaughn D Hunter et al. Methods Mol Biol. 2022.

Abstract

Injectable biomaterials have been developed as potential minimally invasive therapies for treating myocardial infarction (MI) and heart failure. Christman et al. first showed that the injection of a biomaterial alone into rat myocardium can improve cardiac function after MI. More recently, hydrogel forms of decellularized extracellular matrix (ECM) materials have shown substantial promise. Here, we present the methods for fabricating an injectable cardiac-specific ECM biomaterial with demonstrated positive outcomes in small and large animal models for cardiac repair as well as initial safety in a Phase I clinical trial. This chapter also covers the methods for the injection of a biomaterial into rat myocardium using a surgical approach through the diaphragm. Although the methods shown here are for injection of an acellular biomaterial, cells or other therapeutics could also be added to the injection for testing other regenerative medicine strategies.

Keywords: Cardiac repair; Decellularization; Extracellular matrix; Hydrogel; Injectable; Rat.

PubMed Disclaimer

References

    1. Christman KL, Fok HH, Sievers RE et al (2004) Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 10(3–4):403–409 - DOI
    1. Christman K, Vardanian A, Fang Q et al (2004) Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44(3):654–660 - DOI
    1. Johnson TD, Christman KL (2012) Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction. Expert Opin Drug Deliv 10(1):59–72 - DOI
    1. Rane AA, Christman KL (2011) Biomaterials for the treatment of myocardial infarction: a 5-year update. J Am Coll Cardiol 58(25):2615–2629 - DOI
    1. Singelyn JM, DeQuach JA, Seif-Naraghi SB et al (2009) Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 30(29):5409–5416. Elsevier Ltd - DOI

LinkOut - more resources